
By Fredrik Arnold : This monthly report series began applying dog dividend methodology to each of eight major market sectors in December. The sectors were, in alphabetical order: basic materials; consumer goods; financial; healthcare; industrial goods; services; technology; utilities. A ninth ...
By Kapitall : Interested in the growth prospects of the biotech industry? For a closer look at stocks of the biotech sector with positive market sentiment, we ran a screen. We began by screening the biotech industry for stocks currently rallying above their 20-day, 50-day, and 200-day moving ...
LUTHP) 1,630 0.37 N/A Roth: Norfolk Southern NSC 3,316 0.76 Roth: Paychex PAYX 956 0.22 Roth: PDL BioPharma PDLI 1,394 0.32 N/A Roth: Procter & Gamble PG 1,668 0.38 Roth: Prospect Capital PSEC 1,456 0.33 N/A
By ValueMax : In recent years, Abbott Laboratories ( ABT ) has been everything a buy-and-hold investor might want. In the past 10 years, its earnings have increased an average of 8% and book value has increased an average of 10%. It has raised its dividend every year. In fact, the dividend has gone
PDL BioPharma ( PDLI ): Q1 EPS of $0.29 beats by $0.02 . Revenue of $77.3M (-7.2% Y/Y) in-line. ( PR ) Post your comment!
PDL BioPharma , Inc. ( PDLI ) Q1 2012 Earnings Call May 3, 2012 4:30 p.m. ET Executives ..... Capital Markets Presentation Operator Good afternoon and welcome to PDL BioPharma ’s First Quarter 2012 Earnings Conference Call. Today’s call
By Kapitall : Do you like to follow the buying trends of smart money investors like hedge fund managers? For a closer look at stocks that the smart money is buying up, we ran a screen. We began by screening the healthcare sector for stocks that appear undervalued relative to earnings growth, with
By Fredrik Arnold : This monthly report series began applying dog dividend methodology to each of eight major market sectors in December. The sectors were, in alphabetical order: basic materials; consumer goods; financial; healthcare; industrial goods; services; technology; utilities. A ninth ...
a 9% plus dividend looks intriguing here. PDL BioPharma ( PDLI ) - " PDL BioPharma , Inc. engages in the management of antibody ..... description from Yahoo Finance ) 7 reasons PDL BioPharma is a great pick up for just over $6 a share
By Kapitall : The healthcare sector is generally known as a growth sector, especially because it includes industries such as biotech. However the sector is diverse and also includes mega-cap drug companies and health insurance providers as well. These industries contribute to healthcare's defensive